Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y. F. Li Yim, et al.
Journal of Crohn s and Colitis (2021) Vol. 16, Iss. 4, pp. 668-681
Open Access | Times Cited: 13

Showing 13 citing articles:

The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
Huimin You, Yue Tan, Dawei Yu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 48
Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review
Pavlo Petakh, Khrystyna Duve, Valentyn Oksenych, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency
Pamela J. Smolak, MyTrang Nguyen, Christine Diamond, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 3, pp. 798-812
Open Access | Times Cited: 6
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
A CCL2+DPP4+ subset of mesenchymal stem cells expedites aberrant formation of creeping fat in humans
Fengfei Wu, Fangting Wu, Qian Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
HDAC inhibitors and IBD: Charting new approaches in disease management
Xueting Du, Weilai Yu, Fangyu Chen, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114193-114193
Closed Access
Histone deacetylase in inflammatory bowel disease: novel insights
Chunxiao Li, Shaobo Gu, Yihong Zhang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
Ahmed M I Elfiky, Ishtu Hageman, M Becker, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2846-2846
Open Access | Times Cited: 7
Origin and Function of Monocytes in Inflammatory Bowel Disease
Xiping Liao, Ji Liu, Xiaolong Guo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2897-2914
Open Access | Times Cited: 1
Role of histone deacetylase inhibitors in non-neoplastic diseases
Chunxiao Zhou, Dengke Zhao, Chunyan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33997-e33997
Open Access | Times Cited: 1
Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia
Rebecca C. Furze, Mária Judit Molnár, Nigel J. Parr, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 12, pp. 5238-5256
Open Access | Times Cited: 3
The ester-containing prodrug NT-0796 enhances delivery of the NLRP3 inflammasome inhibitor NDT-19795 to monocytic cells expressing carboxylesterase-1
John R. Doedens, Christine Diamond, David Harrison, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116455-116455
Open Access
Agmatine attenuates the severity of immunometabolic disorders by suppressing macrophage polarization: an in vivo study using an ulcerative colitis mouse model
Suyue Zhang, Zhen Sun, Yajuan Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117549-117549
Open Access
Page 1

Scroll to top